Yellow fever vaccine Foundation to improve the vaccine from the "Asibi" strain, discovered that a favorable chance mutation in the attenuated virus had produced a highly efficacious strain that was named 17D. After field trials in Brazil, over one million people were vaccinated by 1939, without severe complications. For his work on the yellow fever vaccine, Theiler received the 1951 Nobel Prize in Physiology or Medicine. Only the 17D vaccine remains in use today. The outbreak of yellow fever in Angola in January 2016 has raised concerns about whether the global supply of vaccine is adequate to meet the need during a large
Nobel Prize money. Further costs to pay institutions and persons engaged in giving the prizes were 27,4 million krona. The events during the Nobel week in Stockholm and Oslo cost 20,2 million krona. The administration, Nobel symposium, and similar items had costs of 22.4 million krona. The cost of the Economic Sciences prize of 16.5 Million krona is paid by the Sveriges Riksbank. Once the Nobel Foundation and its guidelines were in place, the Nobel Committees began collecting nominations for the inaugural prizes. Subsequently, they sent a list of preliminary candidates to the prize-awarding institutions. The Nobel Committee's Physics Prize shortlist cited